Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease

Archive ouverte

Zaloszyc, Ariane | Bernardor, Julie | Bacchetta, Justine | Laverny, Gilles | Schmitt, Claus Peter

Edité par CCSD ; MDPI -

International audience. Patients with chronic kidney disease (CKD) inevitably develop mineral and bone disorders (CKD–MBD), which negatively impact their survival and quality of life. For a better understanding of underlying pathophysiology and identification of novel therapeutic approaches, mouse models are essential. CKD can be induced by surgical reduction of a functional kidney mass, by nephrotoxic compounds and by genetic engineering specifically interfering with kidney development. These models develop a large range of bone diseases, recapitulating different types of human CKD–MBD and associated sequelae, including vascular calcifications. Bones are usually studied by quantitative histomorphometry, immunohistochemistry and micro-CT, but alternative strategies have emerged, such as longitudinal in vivo osteoblast activity quantification by tracer scintigraphy. The results gained from the CKD–MBD mouse models are consistent with clinical observations and have provided significant knowledge on specific pathomechanisms, bone properties and potential novel therapeutic strategies. This review discusses available mouse models to study bone disease in CKD.

Consulter en ligne

Suggestions

Du même auteur

Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease

Archive ouverte | Zaloszyc, Ariane | CCSD

International audience. Patients with chronic kidney disease (CKD) inevitably develop mineral and bone disorders (CKD-MBD), which negatively impact their survival and quality of life. For a better understanding of u...

Inactivation of Osteoblast PKC Signaling Reduces Cortical Bone Mass and Density and Aggravates Renal Osteodystrophy in Mice with Chronic Kidney Disease on High Phosphate Diet

Archive ouverte | Zaloszyc, Ariane | CCSD

International audience. Chronic kidney disease (CKD) frequently leads to hyperphosphatemia and hyperparathyroidism, mineral bone disorder (CKD-MBD), ectopic calcifications and cardiovascular mortality. PTH activates...

The use of cinacalcet after pediatric renal transplantation: an international CERTAIN Registry analysis

Archive ouverte | Bernardor, Julie | CCSD

International audience

Chargement des enrichissements...